ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,183Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 2094

$918K Total Retail Price of All Prescriptions

Rank: 118 out of 2094

469 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 11,944 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
FUROSEMIDE 604 582 1 6
SIMVASTATIN 403 377 2 1
LEVOTHYROXINE SODIUM 373 348 3 3
WARFARIN SODIUM 369 344 4 11
AMLODIPINE BESYLATE 360 341 5 2
OMEPRAZOLE 359 338 6 4
DONEPEZIL HCL 327 327 7 20
POTASSIUM CHLORIDE 322 320 8 24
METOPROLOL TARTRATE 251 231 9 10
CITALOPRAM HBR 205 184 10 47
ZOLPIDEM TARTRATE 196 179 11 14
METOPROLOL SUCCINATE 187 178 12 9
LISINOPRIL 186 168 13 7
GABAPENTIN 169 155 14 23
OXYCODONE-ACETAMINOPHEN 163 153 S2 15 40
DIOVAN 161 147 16 13
NAMENDA 158 158 17 32
CARVEDILOL 156 154 18 19
AZITHROMYCIN 140 120 19 27
ATENOLOL 134 130 20 21
QUETIAPINE FUMARATE 134 130 20 71
LOSARTAN POTASSIUM 131 129 22 17
NEXIUM 129 115 23 16
FENTANYL 123 100 S2 24 68
VENLAFAXINE HCL ER 123 105 24 183
METFORMIN HCL 112 91 26 8
ESCITALOPRAM OXALATE 111 108 27 46
MIRTAZAPINE 111 109 27 43
RAMIPRIL 109 106 29 48
PANTOPRAZOLE SODIUM 108 98 30 37
TRICOR 99 75 31 99
FAMOTIDINE 97 71 32 34
PRAVASTATIN SODIUM 97 83 32 18
DIGOXIN 96 96 34 51
CLOPIDOGREL 95 87 35 22
ATORVASTATIN CALCIUM 93 84 36 5
LANTUS SOLOSTAR 92 75 37 76
ALENDRONATE SODIUM 88 74 38 30
HYDROCHLOROTHIAZIDE 86 75 39 12
POLYETHYLENE GLYCOL 3350 82 81 40 75
ACETAMINOPHEN-CODEINE 77 52 S3 41 129
JANUVIA 77 61 41 35
TAMSULOSIN HCL 73 70 43 29
ADVAIR DISKUS 73 71 43 36
SERTRALINE HCL 71 66 45 26
CRESTOR 69 63 46 15
FLUTICASONE PROPIONATE 68 49 47 41
DIVALPROEX SODIUM 68 42 47 69
LIDODERM 67 63 49 59
PLAVIX 66 66 50 38
SEROQUEL 65 65 51 172
PROAIR HFA 63 63 52 45
RISPERIDONE 63 51 52 56
NOVOLOG FLEXPEN 62 47 54 142
KLOR-CON M20 62 62 54 106
CLONIDINE HCL 58 45 56 62
ENALAPRIL MALEATE 58 57 56 25
PEN NEEDLE 55 51 58 136
IPRATROPIUM-ALBUTEROL 55 55 58 92
ISOSORBIDE MONONITRATE ER 54 54 60 57
AGGRENOX 53 49 61 260
LEVOFLOXACIN 53 49 61 70
PAROXETINE HCL 52 48 63 77
PRAMIPEXOLE DIHYDROCHLORIDE 51 39 64 250
TRAMADOL HCL-ACETAMINOPHEN 50 47 65 100
LEVETIRACETAM 50 49 65 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.